Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 1, 1995
Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release
P C Waldmeier, P Wicki, W Fröstl, et al.
British Journal of Pharmacology
|
December 1, 1994
GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors
P C Waldmeier, P Wicki, J J Feldtrauer, et al.
Molecular and Cellular Neurosciences
|
October 15, 1998
Developmental changes of agonist affinity at GABABR1 receptor variants in rat brain
B Malitschek, D Rüegg, J Heid, et al.
European Journal of Pharmacology
|
October 14, 1986
Ifoxetine, a compound with atypical effects on serotonin uptake
P C Waldmeier, L Maître, P A Baumann, et al.
Brain Research. Molecular Brain Research
|
October 16, 1999
Characterisation and partial purification of the GABA(B) receptor from the rat cerebellum using the novel antagonist [3H]CGP 62349
M J Keir, M J Barakat, K K Dev, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1992
Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors
R Bernasconi, J Lauber, C Marescaux, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 1, 1990
CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure
P C Waldmeier, P A Baumann, J J Feldtrauer, et al.
Neuroscience Letters
|
December 15, 1989
CGP 31358 binds to a site on the NMDA receptor that is coupled to both the transmitter recognition site and the channel domain
J Baud, K Thedinga, C Portet, et al.
The Journal of Biological Chemistry
|
May 1, 1999
Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding
T Galvez, M L Parmentier, C Joly, et al.
European Journal of Pharmacology
|
December 29, 1998
Morpholin-2-yl-phosphinic acids are potent GABA(B) receptor antagonists in rat brain
J Ong, D I Kerr, H Bittiger, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 1, 1995
Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release
P C Waldmeier, P Wicki, W Fröstl, et al.
British Journal of Pharmacology
|
December 1, 1994
GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors
P C Waldmeier, P Wicki, J J Feldtrauer, et al.
Molecular and Cellular Neurosciences
|
October 15, 1998
Developmental changes of agonist affinity at GABABR1 receptor variants in rat brain
B Malitschek, D Rüegg, J Heid, et al.
European Journal of Pharmacology
|
October 14, 1986
Ifoxetine, a compound with atypical effects on serotonin uptake
P C Waldmeier, L Maître, P A Baumann, et al.
Brain Research. Molecular Brain Research
|
October 16, 1999
Characterisation and partial purification of the GABA(B) receptor from the rat cerebellum using the novel antagonist [3H]CGP 62349
M J Keir, M J Barakat, K K Dev, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1992
Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors
R Bernasconi, J Lauber, C Marescaux, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 1, 1990
CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure
P C Waldmeier, P A Baumann, J J Feldtrauer, et al.
Neuroscience Letters
|
December 15, 1989
CGP 31358 binds to a site on the NMDA receptor that is coupled to both the transmitter recognition site and the channel domain
J Baud, K Thedinga, C Portet, et al.
The Journal of Biological Chemistry
|
May 1, 1999
Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding
T Galvez, M L Parmentier, C Joly, et al.
European Journal of Pharmacology
|
December 29, 1998
Morpholin-2-yl-phosphinic acids are potent GABA(B) receptor antagonists in rat brain
J Ong, D I Kerr, H Bittiger, et al.
Page
of 5